Northrop Grumman Corporation’s Stock Price Dips to $484.93, Marking a 1.15% Decrease: Is it Time to Buy?

Northrop Grumman Corporation (NOC)

484.93 USD -5.66 (-1.15%) Volume: 1.4M

Northrop Grumman Corporation’s stock price stands at 484.93 USD, experiencing a slight dip of -1.15% this trading session with a trading volume of 1.4M, yet maintaining a positive YTD performance with a rise of +3.33%.

Latest developments on Northrop Grumman Corporation

Northrop Grumman‘s stock price saw movement today following several key events. The company secured a $267 million deal to supply MQ-4C Triton Drones to the US Navy, while also receiving an award from Marotta Controls. Janicki Industries earned their second consecutive supplier award from Northrop Grumman, further highlighting the company’s strong partnerships. Additionally, Northrop Grumman‘s AN/ALQ-257 IVEWS testing is nearly complete, awaiting a production decision from the USAF. Amidst these positive developments, various financial institutions made moves in their stock holdings with Northrop Grumman, including Great Lakes Advisors LLC increasing their stake and PNC Financial Services Group Inc. selling shares. These events collectively impacted the stock price of Northrop Grumman today.

Northrop Grumman Corporation on Smartkarma

Analyst coverage on Northrop Grumman on Smartkarma has been positive, with reports from Baptista Research highlighting the company’s strong financial performance and market position. In their report titled “Northrop Grumman: Does Its Role in National Security Really Shield It From Market Volatility? – Major Drivers,” the analysts noted the company’s record backlog of approximately $91.5 billion and a book-to-bill ratio of 1.23x, indicating strong demand in both domestic and international markets. New contract wins and ongoing programs like Poland’s IBCS system have contributed to this positive outlook.

In another report by Baptista Research titled “Northrop Grumman Corporation: Expansion of Sentinel & GPI Programs & Other Major Drivers,” the analysts emphasized the company’s compelling performance in the aerospace and defense sector. Northrop Grumman‘s robust backlog, reaching a record $85 billion, and impressive book-to-bill ratio demonstrate the continued demand for its defense technologies. Overall, analyst sentiment on Northrop Grumman remains bullish, with a focus on the company’s strategic growth drivers and market resilience.

A look at Northrop Grumman Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Northrop Grumman Corporation, a global security company, has received a mixed outlook based on the Smartkarma Smart Scores. While the company scored well in areas such as dividends and momentum, with a score of 4 in each, it scored lower in resilience with a score of 2. This indicates that Northrop Grumman may face challenges in terms of withstanding economic downturns or market volatility in the long run.

Looking ahead, Northrop Grumman‘s overall outlook seems positive, with a balanced score across various factors such as value, growth, and momentum. With a strong focus on dividends and a solid momentum score, the company may continue to attract investors seeking stable returns. However, the lower resilience score suggests that Northrop Grumman may need to address potential vulnerabilities to ensure sustained growth and success in the future.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma